SCM
Sio Capital Management’s Moleculin Biotech MBRX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-271,230
| Closed | -$116K | – | 46 |
|
2023
Q3 | $116K | Sell |
271,230
-32,159
| -11% | -$13.7K | 0.04% | 47 |
|
2023
Q2 | $176K | Sell |
303,389
-707,567
| -70% | -$410K | 0.04% | 35 |
|
2023
Q1 | $971K | Sell |
1,010,956
-25,897
| -2% | -$24.9K | 0.48% | 30 |
|
2022
Q4 | $1.1M | Hold |
1,036,853
| – | – | 0.41% | 28 |
|
2022
Q3 | $1.1M | Hold |
1,036,853
| – | – | 0.35% | 29 |
|
2022
Q2 | $1.5M | Sell |
1,036,853
-3,676
| -0.4% | -$5.33K | 0.56% | 34 |
|
2022
Q1 | $1.85M | Hold |
1,040,529
| – | – | 0.61% | 34 |
|
2021
Q4 | $1.94M | Hold |
1,040,529
| – | – | 0.58% | 42 |
|
2021
Q3 | $3.12M | Buy |
1,040,529
+35,684
| +4% | +$107K | 1% | 33 |
|
2021
Q2 | $3.69M | Buy |
1,004,845
+41,845
| +4% | +$154K | 0.92% | 38 |
|
2021
Q1 | $3.93M | Buy |
+963,000
| New | +$3.93M | 0.8% | 42 |
|